A multicenter phase III randomized double-blind placebo controlled trial of pravastatin added to first-line standard chemotherapy in patients with small cell lung cancer (SCLC).
Michael Seckl
No relevant relationships to disclose
Christian Ottensmeier
No relevant relationships to disclose
Michael H. Cullen
No relevant relationships to disclose
Peter Schmid
No relevant relationships to disclose
Lindsay E. James
No relevant relationships to disclose
Christina Wadsworth
No relevant relationships to disclose
Hannah Farrant
No relevant relationships to disclose
Dakshinamoorthy Muthukumar
No relevant relationships to disclose
Joyce Thompson
No relevant relationships to disclose
Susan Harden
No relevant relationships to disclose
Gary William Middleton
No relevant relationships to disclose
Kate Fife
No relevant relationships to disclose
Barbara Crosse
No relevant relationships to disclose
Paul Taylor
No relevant relationships to disclose
Iftekhar Khan
No relevant relationships to disclose